Business Standard

Deal valuations weigh on Apollo Hospitals Enterprise, stock declines

Despite valuation concerns, brokerages believe the transaction is positive for the new entity

Apollo Hospitals
Premium

The FIRM’S share declined due to a lower valuation for subsidiary Apollo HealthCo (AHL) and aggressive valuation for Keimed, a promoter-owned drug wholesaler that is merging with AHL

Ram Prasad Sahu

Listen to This Article

The stock of Apollo Hospitals Enterprise (AHEL), India's largest listed health care services company, fell 4.6 per cent on Monday and slipped another 0.34 per cent to close at Rs 5,946.20 on Tuesday. The share declined due to lower valuation for subsidiary Apollo HealthCo (AHL) and aggressive valuation for Keimed, a promoter-owned drug wholesaler that is merging with AHL.

AHEL, in a two-step process, is selling a partial stake in AHL and merging Keimed with AHL, a digital healthcare and omnichannel pharmacy. While views on Keimed vary, most brokerages have pegged higher valuations for AHL. AHEL is raising equity capital

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in